|1.||Josefsson, Elisabet: 5 articles (02/2008 - 02/2004)|
|2.||Vogt, P H: 4 articles (06/2012 - 10/2000)|
|3.||Patti, Joseph M: 4 articles (08/2006 - 11/2003)|
|4.||Wang, Feng: 3 articles (07/2015 - 07/2010)|
|5.||Zimmer, J: 3 articles (06/2012 - 02/2011)|
|6.||Said, Kamaleldin B: 3 articles (02/2010 - 01/2009)|
|7.||Zhao, Xin: 3 articles (02/2010 - 01/2009)|
|8.||Morand, Eric F: 3 articles (01/2009 - 10/2003)|
|9.||Palmqvist, Niklas: 3 articles (12/2005 - 02/2004)|
|10.||Tarkowski, Andrzej: 3 articles (12/2005 - 02/2004)|
06/01/2015 - "Tumour necrosis factor-a (TNF-α) is an important cytokine involved in initiation and progression of renal diseases. "
11/01/2014 - "Tumour necrosis factor a (TNFa) is a proinflammatory cytokine in the pathogenesis of PCOS. "
01/01/2014 - "Human umbilical vein endothelial cells (HUVEC) was treated with tumour necrosis factor a (TNF-α, 10 ng/ml) for 24 hours, and then HUVEC and the culture medium were respectively collected. "
09/01/2011 - "The suppression of airway hyper-responsiveness was mediated through the recruitment of gd T cells; however, the suppression of dendritic cells and T cells was mediated through a distinct mechanism that could not be overcome by the local administration of activated dendritic cells, or by the in vivo administration of tumour necrosis factor a. "
01/01/2011 - "The pro-inflammatory cytokine tumour necrosis factor-a (TNF-α) is increased in serum and CSF in AD. "
09/01/2012 - "Most importantly, in conditions where clearance of infected APC by virus-specific CTL represents a limiting factor, a significant enhancement of CTL responses to the tumor epitope can be detected in cultures stimulated with rVV-MUS12, as compared to those stimulated by rVV-MART alone. "
01/01/2015 - "It has been recently demonstrated that HBZ (HTLV-1 bZIP factor), a protein encoded by the minus strand of HTLV-1 genome, constantly expressed in infected cells and in ATL tumor cells, is also involved in the pathogenesis of leukaemia. "
01/01/2014 - "It was first identified as a neurotrophic factor and later as the most potent natural antiangiogenic factor, a stem cell niche factor, and an inhibitor of cancer cell growth. "
01/01/2014 - "Metastatic tumors to the gingiva and the presence of teeth as a contributing factor: a literature analysis."
09/01/2012 - "Apart from the dose penalty factor, a distance-based exponential function was employed taking the specific tumor geometry into account. "
|3.||Crohn Disease (Crohn's Disease)
05/21/1988 - "Experimental animal studies have not thus far supported a specific pathogenetic factor, a situation ascribed to the fact that the standard requirements of an "ideal" animal model are unsuited to diseases with a multifactorial pathogenesis such as Crohn's disease. "
11/01/2010 - "Antitumor necrosis factor a agents have significantly improved the management of Crohn's disease (CD), but not all patients benefit from this therapy. "
04/01/2005 - "Infliximab is a chimeric monoclonal antibody directed against tumour necrosis factor, a key cytokine in the inflammatory cascade of many diseases, including Crohn's disease. "
06/01/2002 - "Although effective in the treatment of refractory Crohn's disease, episodic retreatment with the antitumor necrosis factor a chimeric monoclonal antibody infliximab (Remicade, Centocor, Malvern, PA) can be associated with severe acute and delayed systemic reactions. "
06/01/1990 - "Factor A was very effective against Staphylococcus aureus and Streptococcus pyogenes infections in mice (sc ED50s of 3.3 approximately 2.4 mg/kg x 2, respectively). "
10/05/2015 - "Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection."
04/04/2015 - "[Advances in baculovirus per os infection and per os infectivity factor--A review]."
01/01/2010 - "mA3 is linked to the Rfv3 virus resistance factor, a gene responsible for recovery from infection by Friend murine leukemia virus, and mA3 allelic variants differ in their ability to restrict mouse mammary tumor virus. "
12/01/2009 - "Whatever the immunocompromising factor, a common denominator which facilitates the occurrence of tumours, infections and dysimmune reactions in an immunocompromised district may reside in locally hampered lymph drainage and/or locally altered neuromediator signalling. "
04/15/1987 - "When A204 cells, which are derived from a rhabdomyosarcoma and exclusively synthesize type V procollagen, were incubated with the fibrogenic factor, a 3-4-fold stimulation of the synthesis of both pro-alpha 1(V) and pro-alpha 2(V) chains was seen. "
06/01/2013 - "Key findings from recent Children's Oncology Group (COG) clinical trials include safe reduction in therapy for low risk rhabdomyosarcoma (RMS), validation of FOXO1 fusion as a prognostic factor, a modest improvement in outcome for high-risk RMS, and a biologically designed non-cytotoxic therapy for pediatric desmoid tumor. "
01/01/1994 - "Insulin-like growth factor-II plays a role in Wilm's tumor, neuroblastoma, and rhabdomyosarcoma, either as a proliferation factor, a motility factor, or both. "
|3.||Fibrinogen (Factor I)
|4.||Interleukin-17 (Interleukin 27)
|5.||TNFR-Fc fusion protein (etanercept)
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|10.||Interleukin-6 (Interleukin 6)
|2.||Renal Dialysis (Hemodialysis)
|3.||Drug Therapy (Chemotherapy)
|4.||Cardiopulmonary Resuscitation (CPR)